Kemocarb 150mg Injection

Kemocarb 150mg Injection

Prescription requiredRx Required

Salt Composition: Carboplatin

Expiry Date: 01/2028

Special offer

Buy at $35.01

$35.01

Inclusive of all taxes

▼

1 Vial

About The Product

Chemotherapy Drug, Ovaries Cancer, Lung Cancer

Description

Kemocarb 150mg Injection contains carboplatin 150 mg as an active ingredient. It is used to treat ovarian cancer and small cell lung cancer.

It works by interfering with the genetic material of the cancer cells to slow down or stop the growth of cancer cells. It should be given intravenously by healthcare professional only do not self administer this injection.

Don't take more than the recommended dose.

Uses

  • Ovarian cancer
  • Small cell lung cancer

Side Effects

Kemocarb 150mg Injection  can cause multiple side effects, most of which are mild to moderate and often temporary. Patients are advised to inform their healthcare provider immediately if symptoms stays for prolonged period of time.  

Common side effects include:

  • Nausea
  • Vomiting
  • Anemia
  • Fatigue
  • Low blood platelets
  • Increased liver enzymes
  • Decreased white blood cell count (neutrophils)
  • Stomatitis (Inflammation of the mouth)
  • Peripheral neuropathy (tingling and numbness of feet and hand)
  • Diarrhea

How To Use

  • Kemocarb 150mg is available in injection form and is advised to be taken as per the doctor's prescription. It should be administered by a doctor or experienced nurse under strict medical supervision.Taking this injection in the wrong way may give you severe side effects.
  • In case of overdose, contact your healthcare provider or doctor and they will provide you with medical attention. Missing or overdosing will impact the overall health of the patients and may also have side effects. So, it is always advisable to follow the prescription of the doctor strictly.


How It Works

  • Kemocarb 150mg Injection is an anticancer medicine with carboplatin as an active ingredient. It is an alkylating agent that works by destroying genetic material like DNA or RNA of the cancer cells to prevent the replication of rapidly growing cancer cells.
  • Carboplatin causes the DNA strands to cross-link, that stops the cells from dividing and ultimately leads to their death. As it can cause some adverse impact on the body because it affects both healthy & cancerous cells.


Safety Advice

Alcohol

Avoid the consumption of alcohol while taking Kemocarb 150mg Injection, as alcohol can decrease the effectiveness of the medicine as well as worsen the symptoms.

Pregnancy

Do not take Kemocarb 150mg Injection without consulting the doctor in case of pregnancy, as it can be unsafe to take it during this period.

Breast Feeding

Breastfeeding women should discuss the potential risks and benefits of the Kemocarb 150mg Injection with their healthcare provider before starting treatment.

Driving

Kemocarb 150mg Injection may cause side effects such as dizziness or lack of concentration, which could affect your ability to drive. So it's better to avoid driving.

Kidney

Share your medical history with the doctor before starting the Kemocarb 150mg Injection. Do not take it without consulting a doctor if you have any kidney related issue.

Liver

Kemocarb 150mg Injection is safe for use in liver disease if prescribed by the doctor. No dosage adjustment is necessary for this Tablet.

FAQs

Kemocarb 150mg Injection can be given into a vein (intravenously) by a doctor or nurse under strict medical supervision.

References

  • Sousa, G. F. D., Wlodarczyk, S. R., & Monteiro, G. (2014). Carboplatin: molecular mechanisms of action associated with chemoresistance. Brazilian Journal of Pharmaceutical Sciences, 50(4), 693-701. https://www.scielo.br/j/bjps/a/9F6tZpxsm7spMKjGn6Z3kvr/?lang=en
  • Wagstaff, A. J., Ward, A., Benfield, P., & Heel, R. C. (1989). Carboplatin: a preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the treatment of cancer. Drugs, 37(2), 162-190. https://pubmed.ncbi.nlm.nih.gov/2649354/
  • Oguri, S., Sakakibara, T., Mase, H., Shimizu, T., Ishikawa, K., Kimura, K., & Smyth, R. D. (1988). Clinical pharmacokinetics of carboplatin. The Journal of Clinical Pharmacology, 28(3), 208-215. https://pubmed.ncbi.nlm.nih.gov/3283185/
  • Canetta, R., Rozencweig, M., & Carter, S. K. (1985). Carboplatin: the clinical spectrum to date. Cancer treatment reviews, 12, 125-136. https://pubmed.ncbi.nlm.nih.gov/3002623/
  • Stewart, D. J. (2007). Mechanisms of resistance to cisplatin and carboplatin. Critical reviews in oncology/hematology, 63(1), 12-31. https://pubmed.ncbi.nlm.nih.gov/17336087/

i
Trust & safety

Medical Disclaimer

Accurate, reviewed information to support informed healthcare decisions

For informational purposes only
Not a substitute for professional medical advice
Consult your doctor for diagnosis and treatment

Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.

The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.

This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.

Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.

Always follow advice from your doctor, pharmacist, or other licensed healthcare professional before starting, stopping, or changing any medicine or treatment.
Read full medical disclaimer in Terms & Conditions
Magicine PharmacopyCopyright 2026